Goserline versus danazol in the treatment of endometriosis

In: Annals of King Edward Medical University · 2016 · vol. 12(1) · doi:10.21649/akemu.v12i1.823 · W2424139623
Non-randomised trial OA: diamond CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-10-05 ⓘ

A six-month trial comparing gosereline and danazol for endometriosis treatment found both drugs equally effective for pain relief, though gosereline produced significantly fewer side effects.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-28 · read from full text ⓘ

This experimental study compared the efficacy and side effect profiles of gosereline versus danazol for treating endometriosis symptoms in a cohort of forty patients at Lady Willingdon Hospital. Both medications demonstrated equal effectiveness in providing symptomatic relief, with 40% of patients in each group achieving complete pain resolution over a six-month treatment period. The researchers explicitly noted that while clinical outcomes regarding pain were statistically similar, gosereline was associated with significantly fewer adverse effects than danazol, as indicated by a p-value less than 0.05. This paper is centrally about endometriosis — specifically comparing two pharmacological treatments for symptom management.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Objective: The objective of this study was to achieve symptoms relief of endometriosis with a drug having better efficacy and least side effects. Study Design: Experimental. Place & Duration of Study: Lady Willingdon Hospital, Lahore from March, 2003 to Feb. 2005. Subjects & Methods: The trial was conducted on two groups; one group (n = 20) received goserline and other group (n=20) received danazol for 6 months. Patients were followed for relief of symptoms including dysmenorrhoea, dyspareunia, lower abdominal pain and menstrual irregularity and appearance of side effects. Results: The results depicted that in Danazol group 50% pain relief was found in 5 patients (25%) while in goserline group in 4 patients (20%). 75% pain relief was seen in 7 patients (35%) in danazol group and 8 patients (40%) in goserline group. 100% of improvement in pain found in equal number of patient that is 8(40%) in both groups. Both drugs were effective in pain relief (P >0.05), Goserline had less side effects as compared to Danazol (P<0.05). Conclusion: Goserline and Danazol are equally effective in symptomatic relief of endometriosis while side effects favoured use of GnRH agonist.
Full text 1,810 characters · extracted from oa-doi-fallback · click to expand
Goserline versus danazol in the treatment of endometriosis DOI: https://doi.org/10.21649/akemu.v12i1.823Keywords: Danazol. Endometriosis. Drug Toxicity. Estrogen Antagonists. Pharmaceutical Preparations. Pelvic Pain. Leuprolide. Nafarelin. Gestrinone.Abstract Objective: The objective of this study was to achieve symptoms relief of endometriosis with a drug having better efficacy and least side effects. Study Design: Experimental. Place & Duration of Study: Lady Willingdon Hospital, Lahore from March, 2003 to Feb. 2005. Subjects & Methods: The trial was conducted on two groups; one group (n = 20) received goserline and other group (n=20) received danazol for 6 months. Patients were followed for relief of symptoms including dysmenorrhoea, dyspareunia, lower abdominal pain and menstrual irregularity and appearance of side effects. Results: The results depicted that in Danazol group 50% pain relief was found in 5 patients (25%) while in goserline group in 4 patients (20%). 75% pain relief was seen in 7 patients (35%) in danazol group and 8 patients (40%) in goserline group. 100% of improvement in pain found in equal number of patient that is 8(40%) in both groups. Both drugs were effective in pain relief (P >0.05), Goserline had less side effects as compared to Danazol (P<0.05). Conclusion: Goserline and Danazol are equally effective in symptomatic relief of endometriosis while side effects favoured use of GnRH agonist. Downloads Published How to Cite Issue Section License This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments [email protected]

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisdysmenorrheadyspareunia

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK